Comparison of Autologous Serum Eye Drops with Different Diluents

REFERENCES

• Poon AC, Geerling G, Dart JK, Fraenkel G, Daniels J. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001;85:1188–1197.
   PubMed Web of Science ®Google Scholar
• Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol 2007;144:86–92.
   PubMed Web of Science ®Google Scholar
• Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467–1474.
   PubMed Web of Science ®Google Scholar
• Kojima T, Higuchi A, Goto E, Matsumoto Y, Dogru M, Tsubota K. Autologous serum eye drops for the treatment of dry eye diseases. Cornea 2008;27 Suppl 1:S25–S30.
   Google Scholar
• Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005;139:242–246.
   PubMed Web of Science ®Google Scholar
• Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999;106:1984–1989.
   PubMed Web of Science ®Google Scholar
• Schulze SD, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol 2006;142:207–211.
   PubMed Web of Science ®Google Scholar
• Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 2005;243:706–714.
   PubMed Web of Science ®Google Scholar
• Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren’s syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577–585.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615–621.
   PubMed Web of Science ®Google Scholar
• Bron AJ. The Doyne Lecture. Reflections on the tears. Eye (Lond) 1997;11 (Pt 5):583–602.
   Google Scholar
• Chotikavanich S, de Paiva CS, Li de Q, Chen JJ, Bian F, Farley WJ et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 2009;50:3203–3209.
   PubMed Web of Science ®Google Scholar
• Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221–232.
   PubMedGoogle Scholar
• Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647–652.
   PubMed Web of Science ®Google Scholar
• Laursen AB, Fledelius H. Variations of lens thickness in relation to biomicroscopic types of human senile cataract. Acta Ophthalmol (Copenh) 1979;57:1–13.
   Web of Science ®Google Scholar
• Lagnado R, King AJ, Donald F, Dua HS. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 2004;88:464–465.
   PubMed Web of Science ®Google Scholar
• Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001;20:802–806.
   PubMed Web of Science ®Google Scholar
• Duch-Samper AM, Capdevila C, Menezo JL, Hurtado-Sarrió M. Endothelial toxicity of ceftazidime in anterior chamber irrigation solution. Exp Eye Res 1996;63:739–745.
   Google Scholar
• Lin CP, Boehnke M. Effect of fortified antibiotic solutions on corneal epithelial wound healing. Cornea 2000;19:204–206.
   Google Scholar
• Sosa AB, Epstein SP, Asbell PA. Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells. Cornea 2008;27:930–934.
   PubMed Web of Science ®Google Scholar
• Chung SH, Lee SK, Cristol SM, Lee ES, Lee DW, Seo KY et al. Impact of short-term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin. Mol Vis 2006;12:415–421.
   PubMed Web of Science ®Google Scholar
• Epstein SP, Ahdoot M, Marcus E, Asbell PA. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther 2009;25:113–119.
   PubMed Web of Science ®Google Scholar
• Yanochko GM, Khoh-Reiter S, Evans MG, Jessen BA. Comparison of preservative-induced toxicity on monolayer and stratified Chang conjunctival cells. Toxicol In Vitro 2010;24:1324–1331.
   Google Scholar
• Eriksson P, Andersson C, Ekerfelt C, Ernerudh J, Skogh T. Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjögren’s syndrome, rheumatoid arthritis and healthy controls. Clin Exp Immunol 2004;137:617–620.
   PubMed Web of Science ®Google Scholar
• Mieliauskaite D, Venalis P, Dumalakiene I, Venalis A, Distler J. Relationship between serum levels of TGF-beta1 and clinical parameters in patients with rheumatoid arthritis and Sjögren’s syndrome secondary to rheumatoid arthritis. Autoimmunity 2009;42:356–358.
   PubMed Web of Science ®Google Scholar
• Gomes JA, Amankwah R, Powell-Richards A, Dua HS. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 2004;88:821–825.
   PubMed Web of Science ®Google Scholar
• Shimmura S, Ono M, Shinozaki K, Toda I, Takamura E, Mashima Y et al. Sodium hyaluronate eyedrops in the treatment of dry eyes. Br J Ophthalmol 1995;79:1007–1011.
   PubMed Web of Science ®Google Scholar
• Aragona P, Papa V, Micali A, Santocono M, Milazzo. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002;86:181–184.
   PubMed Web of Science ®Google Scholar
• Camillieri G, Bucolo C, Rossi S, Drago F. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect. J Ocul Pharmacol Ther 2004;20:548–553.
   PubMed Web of Science ®Google Scholar
• Liu L, Tiffany J, Dang Z, Dart JK, Watson SL, Daniels JT et al. Nourish and nurture: development of a nutrient ocular lubricant. Invest Ophthalmol Vis Sci 2009;50:2932–2939.
   Google Scholar
• Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Kasper K et al. Corneal epitheliotrophic capacity of three different blood-derived preparations. Invest Ophthalmol Vis Sci 2006;47:2438–2444.
   PubMed Web of Science ®Google Scholar